This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Sahil S Sangani: Innovator in Antibody Co-Formulations
Introduction
Sahil S Sangani is a notable inventor based in Rahway, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of co-formulations of antibodies. His work focuses on innovative solutions for treating various disorders.
Latest Patents
Sahil holds a patent for "Co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies." This invention provides co-formulations of these antibodies and outlines their use in treating various disorders. His patent portfolio includes 1 patent that showcases his expertise in this area.
Career Highlights
Sahil is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His role involves research and development in the field of immunotherapy, where he applies his knowledge to create effective treatment options.
Collaborations
Throughout his career, Sahil has collaborated with talented professionals, including Yogita Krishnamachari and Valentyn Antochshuk. These collaborations have enhanced his research and contributed to the advancement of innovative therapies.
Conclusion
Sahil S Sangani is a dedicated inventor whose work in antibody co-formulations is paving the way for new treatment options in medicine. His contributions to the field are invaluable and reflect his commitment to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile